Long-term effects of stimulant exposure on cerebral blood flow response to methylphenidate and behavior in attention-deficit hyperactivity disorder

[1]  C. Zeni,et al.  ADHD is associated with migraine: a systematic review and meta-analysis , 2018, European Child & Adolescent Psychiatry.

[2]  A. Zwinderman,et al.  Age-Dependent Effects of Methylphenidate on the Human Dopaminergic System in Young vs Adult Patients With Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. , 2016, JAMA psychiatry.

[3]  M. Caan,et al.  Dopaminergic System Dysfunction in Recreational Dexamphetamine Users , 2015, Neuropsychopharmacology.

[4]  G. Zaharchuk,et al.  Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. , 2015, Magnetic resonance in medicine.

[5]  G. Houston,et al.  Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementia , 2014, Human brain mapping.

[6]  L. Reneman,et al.  Pharmacological imaging as a tool to visualise dopaminergic neurotoxicity , 2014, Neuropharmacology.

[7]  Mariya V. Cherkasova,et al.  Amphetamine-Induced Dopamine Release and Neurocognitive Function in Treatment-Naive Adults with ADHD , 2014, Neuropsychopharmacology.

[8]  K. Humphreys,et al.  Stimulant medication and substance use outcomes: a meta-analysis. , 2013, JAMA psychiatry.

[9]  J. Swanson,et al.  Long-Term Stimulant Treatment Affects Brain Dopamine Transporter Level in Patients with Attention Deficit Hyperactive Disorder , 2013, PloS one.

[10]  Andrea L. Howard,et al.  Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. , 2013, Journal of the American Academy of Child and Adolescent Psychiatry.

[11]  J. Buitelaar.  How Long Should Medication Treatment of ADHD Be Extended , 2012 .

[12]  Xavier Golay,et al.  Improved partial volume correction of ASL images using 3D kernels , 2012 .

[13]  J. Swanson,et al.  Chronic Treatment with Extended Release Methylphenidate Does Not Alter Dopamine Systems or Increase Vulnerability for Cocaine Self-Administration: A Study in Nonhuman Primates , 2012, Neuropsychopharmacology.

[14]  P. Asherson,et al.  The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care , 2012, BMC Pediatrics.

[15]  David C. Alsop,et al.  Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: A multi-class pattern recognition approach , 2012, NeuroImage.

[16]  J. Swanson,et al.  Methylphenidate-Elicited Dopamine Increases in Ventral Striatum Are Associated with Long-Term Symptom Improvement in Adults with Attention Deficit Hyperactivity Disorder , 2012, The Journal of Neuroscience.

[17]  J. Buitelaar,et al.  To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended? , 2011, European Neuropsychopharmacology.

[18]  Ji-Kyung Choi,et al.  Pharmacologic Neuroimaging of the Ontogeny of Dopamine Receptor Function , 2010, Developmental Neuroscience.

[19]  M. Monuteaux,et al.  Do Stimulants Protect Against Psychiatric Disorders in Youth With ADHD? A 10-Year Follow-up Study , 2009, Pediatrics.

[20]  J. Swanson,et al.  The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.

[21]  S. Bálint,et al.  Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis , 2009, British Journal of Psychiatry.

[22]  T. Brown,et al.  Regression algorithm correcting for partial volume effects in arterial spin labeling MRI , 2008, Magnetic resonance in medicine.

[23]  David C. Alsop,et al.  Increased cerebral perfusion in adult attention deficit hyperactivity disorder is normalised by stimulant treatment: A non-invasive MRI pilot study , 2008, NeuroImage.

[24]  S. Andersen,et al.  Juvenile methylphenidate modulates reward‐related behaviors and cerebral blood flow by decreasing cortical D3 receptors , 2008, The European journal of neuroscience.

[25]  B. Birmaher,et al.  Does pharmacotherapy for attention-deficit/hyperactivity disorder predict risk of later major depression? , 2008, Journal of child and adolescent psychopharmacology.

[26]  F. Castellanos,et al.  Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. , 2008, The American journal of psychiatry.

[27]  Daniel Rueckert,et al.  Automatic segmentation of brain MRIs of 2-year-olds into 83 regions of interest , 2008, NeuroImage.

[28]  R. Henderson,et al.  Antidepressant Treatment Can Normalize Adult Behavioral Deficits Induced by Early-Life Exposure to Methylphenidate , 2008, Biological Psychiatry.

[29]  J. Buitelaar,et al.  Reliability, Validity, and Utility of Instruments for Self-Report and Informant Report Concerning Symptoms of ADHD in Adult Patients , 2008, Journal of attention disorders.

[30]  Frank Telang,et al.  Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. , 2007, Archives of general psychiatry.

[31]  R. P. Maguire,et al.  Methylphenidate‐induced activation of the anterior cingulate but not the striatum: A [15O]H2O PET study in healthy volunteers , 2007, Human brain mapping.

[32]  Daniel Rueckert,et al.  Automatic anatomical brain MRI segmentation combining label propagation and decision fusion , 2006, NeuroImage.

[33]  J. Biederman,et al.  Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. , 2006, Clinical therapeutics.

[34]  S. Andersen,et al.  Altering the course of neurodevelopment: a framework for understanding the enduring effects of psychotropic drugs , 2004, International Journal of Developmental Neuroscience.

[35]  T. Wilens.  Impact of ADHD and its treatment on substance abuse in adults. , 2004, The Journal of clinical psychiatry.

[36]  S. Mague,et al.  Enduring behavioral effects of early exposure to methylphenidate in rats , 2003, Biological Psychiatry.

[37]  M. Barrot,et al.  Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood , 2003, Biological Psychiatry.

[38]  J. Swanson,et al.  Serum and brain concentrations of methylphenidate: implications for use and abuse , 2003, Neuroscience & Biobehavioral Reviews.

[39]  Alexander Hammers,et al.  Three‐dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe , 2003, Human brain mapping.

[40]  Joseph Biederman,et al.  Does stimulant therapy of attention‐deficit/hyperactivity disorder beget later substance abuse? , 2003, Pediatrics.

[41]  Scott T. Grafton,et al.  A Positron Emission Tomography Study Of Methylphenidate in Adults with ADHD: Alterations in Resting Blood Flow and Predicting Treatment Response , 2002, Neuropsychopharmacology.

[42]  S. Takashima,et al.  Developmental and age-related changes of dopamine transporter, and dopamine D1 and D2 receptors in human basal ganglia , 1999, Brain Research.

[43]  S Warach,et al.  A general kinetic model for quantitative perfusion imaging with arterial spin labeling , 1998, Magnetic resonance in medicine.

[44]  B R Rosen,et al.  Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data , 1997, Magnetic resonance in medicine.

[45]  David E. Reynolds,et al.  Automatic segmentation , 1986 .

[46]  Liang-Jen Wang,et al.  Attention-deficit hyperactivity disorder, its treatment with medication and the probability of developing a depressive disorder: A nationwide population-based study in Taiwan. , 2016, Journal of affective disorders.

[47]  H. Geurts,et al.  The effects of Psychotropic drugs On the Developing brain (ePOD) study: methods and design , 2016 .

[48]  Schrantee,et al.  Age-dependent effects of methylphenidate on the human dopaminergic system in young vs adult patients with attention- deficit/hyperactivity disorder , 2016 .

[49]  M. Frydenberg,et al.  ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study. , 2014, Addictive behaviors.

[50]  Max A. Viergever,et al.  elastix: A Toolbox for Intensity-Based Medical Image Registration , 2010, IEEE Transactions on Medical Imaging.

[51]  A. Arvanitogiannis,et al.  Altered responsiveness to cocaine in rats exposed to methylphenidate during development , 2002, Nature Neuroscience.

[52]  Peter Herscovitch,et al.  Amphetamine-Induced Dopamine Release , 2001 .

[53]  E. Rüther,et al.  Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters. , 2001, Journal of child and adolescent psychopharmacology.

[54]  Philip Seeman,et al.  Human brain dopamine receptors in children and aging adults , 1987, Synapse.

[55]  P. Swanson,et al.  The effects of the , 1975 .